Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-02-25 @ 11:19 PM
Study NCT ID:
NCT01709760
Status:
UNKNOWN
Last Update Posted:
2018-04-17
First Post:
2012-10-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
Sponsor:
Mycenax Biotech Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TSHEN1101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None